Compare NECB & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NECB | OSUR |
|---|---|---|
| Founded | 1934 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.0M | 275.4M |
| IPO Year | 2021 | 2000 |
| Metric | NECB | OSUR |
|---|---|---|
| Price | $27.89 | $4.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $30.00 | $3.00 |
| AVG Volume (30 Days) | 47.2K | ★ 670.4K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $4.85 | $4.48 |
| Revenue Next Year | $8.45 | $7.76 |
| P/E Ratio | $37.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.27 | $2.08 |
| 52 Week High | $28.94 | $4.58 |
| Indicator | NECB | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 66.75 | 58.92 |
| Support Level | $22.56 | $2.84 |
| Resistance Level | N/A | $4.58 |
| Average True Range (ATR) | 0.77 | 0.20 |
| MACD | 0.17 | -0.03 |
| Stochastic Oscillator | 64.63 | 59.65 |
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.